This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OKLearn moreWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy PolicyDownload the investor presentation by entering your information below
Subscribe to our newsletter to stay up to date on what Supreme Cannabis and its brands are up to.
You can withdraw your consent at any time. You can reach us at info@supreme.ca. Our address is 178R Ossington Avenue, Toronto, ON M6J 2Z7. “We” in the consent above refers to The Supreme Cannabis Company, Inc. Supreme is seeking this consent on its own behalf, but will send messages about itself and its affiliates.
Supreme Pharmaceuticals Inc. Changes Name to the Supreme Cannabis Company Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10 Unsecured Convertible Debenture
/in 2017, Press Release /by adminDECEMBER 18, 2017 TSXV: FIRE TORONTO, Dec. 18, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) is pleased to announce that is has changed its name to “The Supreme Cannabis Company, Inc.” effective today. The name change was approved by the shareholders of the Company at the annual general and special meeting of shareholders […]
Supreme Purchases Adjacent Land for Ultra-Premium Cannabis Facility
/in 2017, Press Release /by adminDECEMBER 18, 2017 TSXV: FIRE TORONTO, Dec. 18, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme or the “Company“) (TSXV:FIRE) is pleased to announce the purchase of an approximately six acre property adjacent to the 7ACRES facility in Kincardine, Ontario. Supreme expects to build an indoor cultivation facility (“Lot 16“) to produce high quality, “California-Style” cannabis for the premium product segment. […]
Supreme Signs High-Quality Flower Supply LOI Agreement with Able BC
/in 2017, Press Release /by adminNOVEMBER 24, 2017 TSXV: FIRE TORONTO, Nov. 24, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) is pleased to announce it has entered into a Letter of Intent (“LOI”) with the Alliance of Beverage Licensees (“ABLE BC”), the advocacy organization representing BC’s private liquor industry. “We are pleased to partner with Supreme as our first licensed producer […]
Supreme Pharmaceuticals Closes $40.25 Million Bought Deal Private Placement of Convertible Debenture Units
/in 2017, Press Release /by adminNOVEMBER 14, 2017 /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSXV: FIRE TORONTO, Nov. 14, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce the closing of its previously announced bought deal private placement of 40,250 convertible debenture units (the “Convertible Debenture Units”), including the exercise of the Underwriters’ over-allotment […]
Supreme Commences Production in New Flowering Rooms
/in 2017, Press Release /by adminNOVEMBER 07, 2017 TSXV: FIRE TORONTO, Nov. 7, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) is pleased to announce 7ACRES has commenced production in the newly constructed flowering rooms recently approved by Health Canada. Yesterday, over 3,000 plants of a specially selected phenotype of cannabis called “Wappa” were hand-transplanted into the first of three […]
Supreme Receives Approval for Increased Capacity at 7ACRES Hybrid Facility
/in 2017, Press Release /by adminOCTOBER 23, 2017 TSXV: FIRE TORONTO, Oct. 23, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) announced today that 7ACRES has obtained the Health Canada approvals necessary to commence cultivation at the recently completed 30,000 sq. ft. flowering rooms at the Company’s Hybrid facility. The additional flowering area consists of three modular 10,000 sq. ft. flowering rooms […]
Supreme Pharmaceuticals Announces Upsize of Previously Announced Bought Deal Private Placement to $35 Million
/in 2017, Press Release /by adminOCTOBER 18, 2017 /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSXV: FIRE TORONTO, Oct. 18, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (the “Company”) (TSXV:FIRE) announced today that it has amended its agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters (the “Underwriters”), to increase the size of its previously announced bought […]
Supreme Pharmaceuticals Announces $30 Million bought Deal Private Placement of Convertible Debenture Units
/in 2017, Press Release /by adminOCTOBER 17, 2017 /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSXV: FIRE TORONTO, Oct. 17, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (the “Company”) (TSXV:FIRE) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters (the “Underwriters”), pursuant to which the Underwriters have agreed to […]
Supreme to Quadruple Capacity at 7ACRES Hybrid Facility
/in 2017, Press Release /by adminOCTOBER 04, 2017 TORONTO, Oct. 4, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) is pleased to announce that 7ACRES has completed construction of three additional 10,000 sq. ft. flowering rooms at its Hybrid Facility, and applied to Health Canada for licensing. Subject to Health Canada approval, the additional flowering rooms will quadruple 7ACRES’ flowering footprint from 10,000 […]
Supreme Crosses Important Revenue Milestone
/in 2017, Press Release /by adminOCTOBER 03, 2017 TSXV: FIRE TORONTO, Oct. 3, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) is pleased to announce that 7ACRES’ first month of sales exceeded $1,500,000, and that such sales will be recorded in the quarter ended September 30, 2017. “Our first sales represent a significant milestone for Supreme and demonstrate our ability to […]
Supreme Engages Leading Financial Communications Firm Bayfield Strategy
/in 2017, Press Release /by adminSEPTEMBER 28, 2017 TSXV: FIRE TORONTO, Sept. 28, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) is pleased to announce that it has retained Bayfield Strategy, Inc. (“Bayfield”) to provide comprehensive Investor and Public Relations. Bayfield will work with Supreme’s leadership team to achieve its broad communications goals to support growth with a focus on expanding capital […]
Supreme Strengthens Leadership team to Prepare for Next Stage of Growth
/in 2017, Press Release /by adminSEPTEMBER 26, 2017 TSXV: FIRE TORONTO, Sept. 26, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE) is pleased to announce exciting changes and additions to our senior leadership team as the Company prepares for growth. “Our business is driven by a commitment to quality. The quality of our products, the quality […]
Supreme Completes Sale with Emerald Health Botanicals Inc.
/in 2017, Press Release /by adminSEPTEMBER 20, 2017 TORONTO, Sept. 20, 2017 (GLOBE NEWSWIRE) — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc. (“Emerald”), a wholly owned subsidiary of Emerald Health Therapeutics, Inc. (TSXV:EMH). Emerald is a Canadian Licensed […]
Supreme Completes First Sales with Aurora Cannabis
/in 2017, Press Release /by adminSEPTEMBER 05, 2017 TORONTO, ONTARIO — September 5, 2017 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV: FIRE)is pleased to announce its wholly owned subsidiary, 7ACRES, has completed its first sale of dried cannabis to Aurora Cannabis Inc. (“Aurora“), one of Canada’s leading Licensed Producers. Aurora will sell cannabis procured from 7ACRES to its medical […]
Supreme Receives Sales Approval
/in 2017, Press Release /by adminJUNE 28, 2017 TORONTO, ONTARIO — (Marketwired) — 06/28/17 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSX VENTURE:FIRE) is pleased to announce that its wholly-owned operating subsidiary, 7ACRES, has been granted its permission to sell under the Access to Cannabis for Medical Purposes Regulations. About Supreme Supreme is a Canadian publicly traded company committed to becoming a leading cultivator and […]
Supreme Announces Listing of Common Shares on the TSX V Under the Symbol FIRE
/in 2017, Press Release /by adminJUNE 01, 2017 TORONTO, ONTARIO — (Marketwired) — 06/01/17 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL)(CSE:SL.CN)(CNSX:SL)(OTC PINK:SPRWF) is pleased to announce that it has received final approval from the TSX Venture Exchange (“TSX.V“) to list the Company’s common shares on the TSX.V. The common shares are expected to begin trading on the TSX.V at […]
Supreme Updates Board of Directors and Provides Licensing Update
/in 2017, Press Release /by adminMAY 08, 2017 TORONTO, ONTARIO — (Marketwired) — 05/08/17 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL)(CSE:SL.CN)(CNSX:SL) is pleased to announce that Mr. Ron Factor, B.A.Sc, MBA, has joined its Board of Directors. Mr. Factor was the founder of the global supply chain management consulting practice at Deloitte Consulting in Toronto. He will replace Mr. […]
Supreme Announces Conditional Approval to List on the TSX V
/in 2017, Press Release /by adminAPRIL 10, 2017 TORONTO, ONTARIO — (Marketwired) — 04/10/17 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL)(CSE:SL.CN) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (“TSX.V“) to list the Company’s common shares on the TSX.V. John Fowler, President and CEO, stated: “Graduating from the CSE to the TSX.V […]
Supreme Announces License Update
/in 2017, Press Release /by adminMARCH 10, 2017 TORONTO, ONTARIO — (Marketwired) — 03/10/17 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL)(CSE:SL.CN) announces that its wholly-owned subsidiary 7 ACRES has received a renewal of its license to cultivate cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR“). Supreme also understands that Health Canada is in the final phase of […]